FLESHER GREGORY J. 4
4 · Novus Therapeutics, Inc. · Filed Mar 18, 2019
Insider Transaction Report
Form 4
FLESHER GREGORY J.
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2019-03-14+25,000→ 171,556 total - Award
Stock Option (Right to Buy)
2019-03-14+90,000→ 90,000 totalExercise: $3.72Exp: 2029-03-14→ Common Stock (90,000 underlying)
Footnotes (2)
- [F1]This represents restricted stock units representing the right to receive shares of the Issuer's Common Stock, which will vest in full on the later of achievement of a performance-related goal or the first anniversary of the grant date.
- [F2]This option represents a right to purchase a total of 90,000 shares of the Issuer's Common Stock, which will vest in equal quarterly installments through the fourth anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through each vesting date.